MENU

CABA Cabaletta Bio Forecast, Technical & Fundamental Analysis

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CABA is expected to report earnings to rise 6.46% to -59 cents per share on November 07

Cabaletta Bio CABA Stock Earnings Reports
Q3'24
Est.
$-0.60
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.07
Q3'23
Beat
by $0.03
The last earnings report on August 08 showed earnings per share of -56 cents, missing the estimate of -54 cents. With 352.23K shares outstanding, the current market capitalization sits at 219.33M.
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFFX27.550.28
+1.03%
Sphere 500 Climate Fund
IENYX31.520.11
+0.35%
Invesco Energy Y
PAPTX11.400.02
+0.18%
PACE Alternative Strategies P2
MNMCX14.84N/A
N/A
Manning & Napier Pro-Blend Mod Term L
OALVX20.62-0.04
-0.19%
Optimum Large Cap Value A

CABA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with PLRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.51%
PLRX - CABA
39%
Loosely correlated
-3.25%
AUTL - CABA
36%
Loosely correlated
+13.17%
IDYA - CABA
35%
Loosely correlated
-1.38%
RCKT - CABA
35%
Loosely correlated
-1.88%
ENTO - CABA
35%
Loosely correlated
-2.94%
More